Journal article

An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin

RW Tothill, A Kowalczyk, D Rischin, A Bousioutas, I Haviv, RK van Laar, PM Waring, J Zalcberg, R Ward, AV Biankin, RL Sutherland, SM Henshall, K Fong, JR Pollack, DDL Bowtell, AJ Holloway

Cancer Research | AMER ASSOC CANCER RESEARCH | Published : 2005


Gene expression profiling offers a promising new technique for the diagnosis and prognosis of cancer. We have applied this technology to build a clinically robust site of origin classifier with the ultimate aim of applying it to determine the origin of cancer of unknown primary (CUP). A single cDNA microarray platform was used to profile 229 primary and metastatic tumors representing 14 tumor types and multiple histologic subtypes. This data set was subsequently used for training and validation of a support vector machine (SVM) classifier, demonstrating 89% accuracy using a 13-class model. Further, we show the translation of a five-class classifier to a quantitative PCR-based platform. Selec..

View full abstract